Incidence and timing of infusion-related reactions in patients with mucopolysaccharidosis type II (Hunter syndrome) on idursulfase therapy in the real-world setting: a perspective from the Hunter Outcome Survey (HOS)

Claudio Feliciani, Bk Burton, Dah Whiteman

Risultato della ricerca: Contributo in rivistaArticolo in rivista

41 Citazioni (Scopus)

Abstract

To evaluate the occurrence of infusion-related reactions (IRRs) in patients with mucopolysaccharidosis type II (MPS II) receiving idursulfase enrolled in the observational database HOS - the Hunter Outcome Survey.
Lingua originaleEnglish
pagine (da-a)113-120
Numero di pagine8
RivistaMolecular Genetics and Metabolism
Volume103
DOI
Stato di pubblicazionePubblicato - 2011
Pubblicato esternamente

Keywords

  • Adolescent
  • Adrenal Cortex Hormones
  • Adult
  • Anti-Allergic Agents
  • Antibodies, Neutralizing
  • Child
  • Child, Preschool
  • Data Collection
  • Databases, Factual
  • Enzyme Replacement Therapy
  • Humans
  • Hypersensitivity
  • Iduronate Sulfatase
  • Incidence
  • Infant
  • Mucopolysaccharidosis II
  • Time Factors
  • Treatment Outcome
  • Young Adult

Fingerprint

Entra nei temi di ricerca di 'Incidence and timing of infusion-related reactions in patients with mucopolysaccharidosis type II (Hunter syndrome) on idursulfase therapy in the real-world setting: a perspective from the Hunter Outcome Survey (HOS)'. Insieme formano una fingerprint unica.

Cita questo